The Case for a Multi-Test POC Analyser
Healthcare systems are under growing pressure to deliver faster diagnoses, improve patient outcomes, and reduce costs. In this environment, multi-test point-of-care (POC) analysers are emerging as valuable tools that bring laboratory-quality testing directly to the patient.
2026-05-18 13:20:25

Unlike single-purpose devices, a multi-test POC analyser can perform a wide range of diagnostic tests from one compact platform. These may include infectious disease screening, cardiac markers, diabetes monitoring, and inflammation testing. This versatility allows healthcare providers to deliver quicker and more efficient care.


One of the biggest advantages is speed. Traditional laboratory testing can take hours or days due to sample transport and processing times. A multi-test POC analyser can deliver results within minutes, enabling clinicians to make immediate treatment decisions during the patient visit. Faster diagnosis often leads to earlier intervention and better outcomes.


Multi-test systems also improve operational efficiency. Instead of managing several individual devices, clinics can consolidate testing onto one platform, reducing training, maintenance, and equipment costs. This is particularly beneficial in primary care, urgent care, pharmacies, and remote healthcare settings.


For patients, the benefits are equally important. Same-visit testing reduces waiting times, avoids unnecessary follow-up appointments, and improves the overall healthcare experience. In rural or underserved areas, these analysers can significantly expand access to essential diagnostics.


As healthcare moves toward more decentralized and patient-centered care, multi-test POC analysers offer a practical solution that combines speed, flexibility, and efficiency. They are not simply convenient diagnostic tools, they are becoming essential components of modern healthcare delivery.

The FIAPro Immunofluorescence Analyser is a multi-test POC analyser.

The analyser is intended for healthcare professionals to aid in diagnosis of many conditions such as cardiovascular diseases, infection, diabetes, pregnancy, inflammatory markers, etc. and all at the point-of-care environment. Multi-test POC is essential - FIAPro makes it effortless.

Manufactured by VitroSens (www.vitrosens.com), the Turkiye company based in Istanbul, they are a medical technology company focused on developing innovative, non-invasive diagnostic solutions to improve disease detection and patient care.

Further Information

For enquiries regarding the FIAPro™ Immunofluorescence Analyser, including assay availability, technical specifications, governance documentation, or discussions with POCT and pathology teams:

📧 info@sussexbiologicals.co.uk

Share:
© Copyright 2025 - Sussex Biologicals Ltd